COVID-19 Seroprevalence in Pregnant Women and Blood Donors (CoVERED)

Centre Hospitalier Universitaire de Besancon

Status: Completed

Conditions: COVID-19 Respiratory Infection

Study type: Observational

Funder types: Other

Identifiers

NCT04893057

2021/601

Details and patient eligibility

About

The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to determine whether these measures are representative of the general population.

Enrollment: 797 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Pregnant women

  • Adult female
  • Admitted to hospital for live birth
  • Informed consent
  • Affiliated to the French social security health insurance scheme

• Blood donors

  • Adult male or female
  • Qualified for whole blood donation (up to 70 years old in France)
  • Informed consent
  • Affiliated to the French social security health insurance scheme

Exclusion criteria

• Legal incapacity or limited legal capacity
• Subject without health insurance coverage
• Exclusion period of another study or exclusion period of the French national healthy volunteer registry

Trial design

797 participants in 2 patient groups

Pregnant women

Description:

Women admitted to hospital for a live birth.

Blood donors

Description:

Subjects qualified for whole blood donation